Background: Inflammatory bowel disease (IBD) is a chronic, relapsing disorder resulting from genetic, immune, microbial, and environmental factors. Therapeutic options have expanded from conventional drugs to biologic agents and targeted small molecules, enabling individualized management.
Aim: This narrative review a...
Anna Zyskowska, Bartosz Seroczyński, J. Woźniak et al.· Quality in Sport· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.